ask our doctors


Colon Cancer Research

Question: What corporation is involved with the colon cancer gene research?

Answer: Bioniche Life Sciences Inc. PO Box 1570 Belleville, Ontario K8N 5J2 Canada Tel: (613) 9668058 Fax: (613)9664177 Bioniche Life Sciences Inc presented data from a study using the company's proprietary Mycobacterial Cell Wall-DNA Complex (MCC) against peritoneal (colon) cancer in rats. The data was presented at the 7th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The study, co-authored by Dr Nigel C Phillips, Chief Scientific Officer and Dr Mario C Filion, Head of Biomedical Research at Bioniche Life Sciences, evaluated the in vitro activity of MCC against DHD/K12/PROb cells, and the in vivo activity of MCC against DHD/K12/PROb peritoneal carcinomatosis in rats. Dr Filion stated that MCC has direct anticancer activity against PROb cells, as demonstrated by its ability to inhibit proliferation and induce apoptosis. Dr Phillips added that repeated intraperitoneal injection of MCC was well tolerated in non-cancer bearing animals. Significant anticancer activity was seen following tumour cell injection and subsequent treatment with MCC (greater than 350% increase in median survival time at day 200) with substantially more treated animals surviving when compared to the control treated animals. Anticancer activity continues to be maintained at day 278 (greater than 480% increase in media survival time), demonstrating the ability of MCC to induce long-duration remission of disease. Bioniche Life Sciences Inc is a research-based, technology-driven Canadian biopharmaceutical company that discovers, develops, manufactures, and markets proprietary products for human and animal health markets worldwide.


Colon Cancer Research News

Got a Limited Screening Budget? Then Colonoscopy's Not Your Test.

Wall Street Journal (blog)
It was a big week for colon-cancer screening research ? a separate study that also used a computer simulation found that so-called virtual colonoscopy, ...
 

Pinnacle News

American Cancer Society wants Michigan to step up its game
Detroit Free Press
 

Earthtimes

Exact Sciences Obtains Exclusive License to OncoMethylome Sciences' DNA ...
MarketWatch (press release)
 

Bradenton Herald

GE Launches Study to Improve Diagnosis of Early Stage Colon Cancer
MarketWatch (press release)
 

More care isn't always better care

Washington Post (blog)
They found no difference in survival time between hospice and non-hospice patients with breast cancer, prostate cancer, and colon cancer. ...
 

Science Centric

Virtual Colonoscopy Misses Mark on Cost
MedPage Today
 

dBTechno

US cancer death rates continue drop: report
Reuters
 

Hospital now offers almost complete liver care

Dayton Daily News
Diagnosed with colon cancer in July 2008, she had major surgery in January 2009, by which time the cancer had spread to her liver. ...
 

iCAD Reports Second Quarter Financial Results

MarketWatch (press release)
When detected early, colon cancer is highly treatable but a low percentage of patients who are recommended to be screened for colon cancer are actually ...
 

Rosetta Genomics to Present at Leerink Swan's Life Science Tools and ...

MarketWatch (press release)
... including without limitation, statements relating to the development of early detection cancer screening products, including a non-invasive colon cancer ...
 

Types of Cancer


Adrenal Cancer Anal Cancer Brain Cancer Colorectal Cancer Endometrial Cancer Esophageal Cancer
Esophageal Cancer Laryngeal Cancer Oral Cancer Penile Cancer Prostatic Cancer Stomach Cancer
Thyroid Cancer Bladder Cancer Bone Cancer Cervix Cancer Heart Cancer Kidney Cancer
Melanoma Cancer Pancreas Cancer Asbestos Cancer